Physical Function Endpoints in Cancer Cachexia Trials; Systematic Review 1 of the Cachexia Endpoints Series

James McDonald; Judith Sayers; Stefan D Anker; Jann Arends; Trude Rakel Balstad PhD; Vickie E Baracos; Leo Brown; Asta Bye PhD; Olav Dajani; Ross Dolan; Marie T Fallon; Eilidh Fraser; Christine Griel; Aleksandra  Grzyb; Marianne Jensen Hjermstad; Mariam Jamal-hanjani; Gunnhild Jacobsen; Stein Kaasa; Donald McMillan; Matthew Maddocks; Iain Philips; Inger Ottestad; Kieran Reid; Mariana Sousa; Melanie Simpson; O. M. Vagnildhaug; Richard Skipworth; Tora Solheim; Barry J A Laird

doi:10.1002/jcsm.13321

Physical Function Endpoints in Cancer Cachexia Trials; Systematic Review 1 of the Cachexia Endpoints Series

James McDonald, Judith Sayers, Stefan D Anker, Jann Arends, Trude Rakel Balstad PhD, Vickie E Baracos, Leo Brown, Asta Bye PhD, Olav Dajani, Ross Dolan, Marie T Fallon, Eilidh Fraser, Christine Griel, Aleksandra Grzyb, Marianne Jensen Hjermstad, Mariam Jamal-hanjani, Gunnhild Jacobsen, Stein Kaasa, Donald McMillan, Matthew MaddocksIain Philips, Inger Ottestad, Kieran Reid, Mariana Sousa, Melanie Simpson, O. M. Vagnildhaug, Richard Skipworth, Tora Solheim, Barry J A Laird

Research output: Contribution to journal › Literature review › peer-review

Original language	English
Journal	Journal of Cachexia, Sarcopenia and Muscle
Volume	14
Issue number	5
Early online date	6 Sept 2023
DOIs	https://doi.org/10.1002/jcsm.13321
Publication status	Published - 1 Oct 2023

Access to Document

10.1002/jcsm.13321Licence: Creative Commons: Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND)

J cachexia sarcopenia muscle - 2023 - McDonald - Physical function endpoints in cancer cachexia clinical trials SystematicFinal published version, 673 KBLicence: Creative Commons: Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND)

Cite this

McDonald, J., Sayers, J., Anker, S. D., Arends, J., Balstad PhD, T. R., Baracos, V. E., Brown, L., Bye PhD, A., Dajani, O., Dolan, R., Fallon, M. T., Fraser, E., Griel, C., Grzyb, A., Hjermstad, M. J., Jamal-hanjani, M., Jacobsen, G., Kaasa, S., McMillan, D., ... Laird, B. J. A. (2023). Physical Function Endpoints in Cancer Cachexia Trials; Systematic Review 1 of the Cachexia Endpoints Series. Journal of Cachexia, Sarcopenia and Muscle, 14(5). https://doi.org/10.1002/jcsm.13321

@article{db6e10be83db46659d49b67b16b7e1e3,

title = "Physical Function Endpoints in Cancer Cachexia Trials; Systematic Review 1 of the Cachexia Endpoints Series",

author = "James McDonald and Judith Sayers and Anker, {Stefan D} and Jann Arends and {Balstad PhD}, {Trude Rakel} and Baracos, {Vickie E} and Leo Brown and {Bye PhD}, Asta and Olav Dajani and Ross Dolan and Fallon, {Marie T} and Eilidh Fraser and Christine Griel and Aleksandra Grzyb and Hjermstad, {Marianne Jensen} and Mariam Jamal-hanjani and Gunnhild Jacobsen and Stein Kaasa and Donald McMillan and Matthew Maddocks and Iain Philips and Inger Ottestad and Kieran Reid and Mariana Sousa and Melanie Simpson and Vagnildhaug, {O. M.} and Richard Skipworth and Tora Solheim and Laird, {Barry J A}",

note = "Funding Information: S. D. A. has received grants and personal fees from Vifor and Abbott Vascular, and personal fees for consultancies, trial committee work and/or lectures from Actimed, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, BioVentrix, Brahms, Cardiac Dimensions, Cardior, Cordio, CVRx, Cytokinetics, Edwards, Farraday Pharmaceuticals, GSK, HeartKinetics, Impulse Dynamics, Novartis, Occlutech, Pfizer, Repairon, Sensible Medical, Servier, Vectorious and V‐Wave. He is named co‐inventor of two patent applications regarding MR‐proANP (DE 102007010834 and DE 102007022367), but he does not benefit personally from the related issued patents. M. F. has received personal fees from Pfizer. M. J.‐H. has received funding from CRUK, NIH National Cancer Institute, IASLC International Lung Cancer Foundation, Lung Cancer Research Foundation, Rosetrees Trust, UKI NETs and NIHR. M. J.‐H. has consulted for, and is a member of, the Achilles Therapeutics Scientific Advisory Board and Steering Committee, has received speaker honoraria from Pfizer, Astex Pharmaceuticals, Oslo Cancer Cluster and Bristol Myers Squibb and is co‐inventor on a European patent application relating to methods to detect lung cancer (PCT/US2017/028013). R. J. E. S. has received personal fees for consultancy from Artelo, Actimed, Faraday and Helsinn; B. L. has received personal fees for consultancy from Artelo, Actimed, Faraday, Kyona Kirin and Toray. Publisher Copyright: {\textcopyright} 2023 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by Wiley Periodicals LLC.",

year = "2023",

month = oct,

day = "1",

doi = "10.1002/jcsm.13321",

language = "English",

volume = "14",

journal = "Journal of Cachexia, Sarcopenia and Muscle",

issn = "2190-5991",

publisher = "Wiley-Blackwell",

number = "5",

}

McDonald, J, Sayers, J, Anker, SD, Arends, J, Balstad PhD, TR, Baracos, VE, Brown, L, Bye PhD, A, Dajani, O, Dolan, R, Fallon, MT, Fraser, E, Griel, C, Grzyb, A, Hjermstad, MJ, Jamal-hanjani, M, Jacobsen, G, Kaasa, S, McMillan, D, Maddocks, M, Philips, I, Ottestad, I, Reid, K, Sousa, M, Simpson, M, Vagnildhaug, OM, Skipworth, R, Solheim, T & Laird, BJA 2023, 'Physical Function Endpoints in Cancer Cachexia Trials; Systematic Review 1 of the Cachexia Endpoints Series', Journal of Cachexia, Sarcopenia and Muscle, vol. 14, no. 5. https://doi.org/10.1002/jcsm.13321

TY - JOUR

T1 - Physical Function Endpoints in Cancer Cachexia Trials; Systematic Review 1 of the Cachexia Endpoints Series

AU - McDonald, James

AU - Sayers, Judith

AU - Anker, Stefan D

AU - Arends, Jann

AU - Balstad PhD, Trude Rakel

AU - Baracos, Vickie E

AU - Brown, Leo

AU - Bye PhD, Asta

AU - Dajani, Olav

AU - Dolan, Ross

AU - Fallon, Marie T

AU - Fraser, Eilidh

AU - Griel, Christine

AU - Grzyb, Aleksandra

AU - Hjermstad, Marianne Jensen

AU - Jamal-hanjani, Mariam

AU - Jacobsen, Gunnhild

AU - Kaasa, Stein

AU - McMillan, Donald

AU - Maddocks, Matthew

AU - Philips, Iain

AU - Ottestad, Inger

AU - Reid, Kieran

AU - Sousa, Mariana

AU - Simpson, Melanie

AU - Vagnildhaug, O. M.

AU - Skipworth, Richard

AU - Solheim, Tora

AU - Laird, Barry J A

N1 - Funding Information: S. D. A. has received grants and personal fees from Vifor and Abbott Vascular, and personal fees for consultancies, trial committee work and/or lectures from Actimed, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, BioVentrix, Brahms, Cardiac Dimensions, Cardior, Cordio, CVRx, Cytokinetics, Edwards, Farraday Pharmaceuticals, GSK, HeartKinetics, Impulse Dynamics, Novartis, Occlutech, Pfizer, Repairon, Sensible Medical, Servier, Vectorious and V‐Wave. He is named co‐inventor of two patent applications regarding MR‐proANP (DE 102007010834 and DE 102007022367), but he does not benefit personally from the related issued patents. M. F. has received personal fees from Pfizer. M. J.‐H. has received funding from CRUK, NIH National Cancer Institute, IASLC International Lung Cancer Foundation, Lung Cancer Research Foundation, Rosetrees Trust, UKI NETs and NIHR. M. J.‐H. has consulted for, and is a member of, the Achilles Therapeutics Scientific Advisory Board and Steering Committee, has received speaker honoraria from Pfizer, Astex Pharmaceuticals, Oslo Cancer Cluster and Bristol Myers Squibb and is co‐inventor on a European patent application relating to methods to detect lung cancer (PCT/US2017/028013). R. J. E. S. has received personal fees for consultancy from Artelo, Actimed, Faraday and Helsinn; B. L. has received personal fees for consultancy from Artelo, Actimed, Faraday, Kyona Kirin and Toray. Publisher Copyright: © 2023 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by Wiley Periodicals LLC.

PY - 2023/10/1

Y1 - 2023/10/1

U2 - 10.1002/jcsm.13321

DO - 10.1002/jcsm.13321

M3 - Literature review

SN - 2190-5991

VL - 14

JO - Journal of Cachexia, Sarcopenia and Muscle

JF - Journal of Cachexia, Sarcopenia and Muscle

IS - 5

ER -